BioPharma Dive - Latest News

Oz hints at impending CMS rule to force drug price transparency

The Trump administration aims to issue a rule empowering regulators to “forcefully” go after companies that don’t share drug cost information, Oz said Tuesday.

Jun 25, 2025 - 15:05
 0
Oz hints at impending CMS rule to force drug price transparency

The Trump administration aims to issue a rule empowering regulators to “forcefully” go after companies that don’t share drug cost information, Oz said Tuesday.

Read More

Tags:

Previous Article

Fierce Biotech Layoff Tracker 2025: BlueRock cuts 50 roles; Prothena lays off 63...

Next Article

STAT+: DeepMind launches AlphaGenome, aiming to predict gene regulation from DNA...

Related Posts

Biogen strikes RNAi deal with City; Aurion withdraws IPO

Biogen strikes RNAi deal with City; Aurion withdraws IPO

May 27, 2025  0

Sage, following Setbacks, to sell to Supernus for $561M

Sage, following Setbacks, to sell to Supernus for $561M

Jun 16, 2025  0

FDA clears Moderna’s new COVID vaccine, but with limits

FDA clears Moderna’s new COVID vaccine, but with limits

May 31, 2025  0